Management of extravasation of oxaliplatin

J Oncol Pharm Pract. 2005 Dec;11(4):159-62. doi: 10.1191/1078155205jp165oa.

Abstract

Oxaliplatin extravasation has been associated with local pain and inflammation which may be severe and lead to complications including necrosis. Recent case reports suggest that oxaliplatin may be better classified as an irritant when extravasated. The optimal management of oxaliplatin extravasation however remains uncertain. Cold compress may cause local vasoconstriction and reduce cellular injury. However, it may potentially precipitate or worsen peripheral neuropathy. Warm compress may increase drug removal by local vasodilation and avoid peripheral neuropathy. However, it may potentially increase cellular uptake and hence injury. Further research into this area is needed.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use
  • Cryotherapy / methods
  • Extravasation of Diagnostic and Therapeutic Materials / diagnosis
  • Extravasation of Diagnostic and Therapeutic Materials / etiology
  • Extravasation of Diagnostic and Therapeutic Materials / therapy*
  • Hot Temperature / therapeutic use
  • Humans
  • Organoplatinum Compounds / administration & dosage
  • Organoplatinum Compounds / adverse effects*
  • Organoplatinum Compounds / therapeutic use
  • Oxaliplatin

Substances

  • Antineoplastic Agents
  • Organoplatinum Compounds
  • Oxaliplatin